Effect of 24 hr treatment with 100 nM PPARγ agonist, rosiglitazone (Rosi), on mRNA expression levels for synuclein-γ (Sncg) in murine primary dorsal root ganglia neurons.
figureposted on 10.03.2015, 03:19 authored by Tamara N. Dunn, Tasuku Akiyama, Hyun Woo Lee, Jae Bum Kim, Trina A. Knotts, Steven R. Smith, Dorothy D. Sears, Earl Carstens, Sean H. Adams
Values are means +/- SEM, n = 17/treatment. Data are from four independent experiments. Transcript level in vehicle-treated control cells was considered 100%. Raw data is provided in S1 Data.
Read the peer-reviewed publication
watLXR agonist T 0901317DRG neuronsadipocyte lipid dropletsPPAR γ agonismlepDorsal Root Ganglia Somatosensory Neuronstype 2 diabetesPPAR γ targetSNCGsynucleindorsal root gangliaPPAR γ antagonist T 0070907. Chromatin immunoprecipitation experimentsPPAR γ protein bindingSncg mRNA expressionHuman Adipose Tissuelipid droplet dynamicsPPAR γ antagonist